128 related articles for article (PubMed ID: 6224732)
1. Some proteins not belonging to the clotting or to the kallikrein-kinin system altered by kallikrein.
Péjaudier L; Kichenin V; Audran R; Steinbuch M
Hoppe Seylers Z Physiol Chem; 1983 Jun; 364(6):651-4. PubMed ID: 6224732
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor.
Moroi M; Aoki N
J Biochem; 1977 Oct; 82(4):969-72. PubMed ID: 144728
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
[TBL] [Abstract][Full Text] [Related]
4. Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.
Harpel PC
J Clin Invest; 1972 Jul; 51(7):1813-22. PubMed ID: 4338122
[TBL] [Abstract][Full Text] [Related]
5. Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.
Eisen V; Loveday C
Br J Pharmacol; 1973 Dec; 49(4):678-87. PubMed ID: 4788038
[TBL] [Abstract][Full Text] [Related]
6. Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema.
Nielsen EW; Johansen HT; Høgåsen K; Wuillemin W; Hack CE; Mollnes TE
Scand J Immunol; 1996 Aug; 44(2):185-92. PubMed ID: 8711433
[TBL] [Abstract][Full Text] [Related]
7. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.
Brus F; van Oeveren W; Okken A; Oetomo SB
Pediatr Res; 1994 Nov; 36(5):647-53. PubMed ID: 7877886
[TBL] [Abstract][Full Text] [Related]
8. [General mechanisms of biochemical regulation of the kallikrein, clotting and fibrinolytic systems of the blood].
Gomazkov OA; Komissarova NV
Usp Sovrem Biol; 1976; 82(6):356-70. PubMed ID: 65846
[No Abstract] [Full Text] [Related]
9. [Comparative evaluation of the kallikrein-kinin, plasmin and thrombin blood systems in hypertension].
Karpitskiĭ VV
Kardiologiia; 1983 Apr; 23(4):98-100. PubMed ID: 6223170
[No Abstract] [Full Text] [Related]
10. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
Schreiber AD; Kaplan AP; Austen KF
J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
[TBL] [Abstract][Full Text] [Related]
13. [Potentiation of kinin activity by products of proteolytic protein degradation].
Czokalo M; Buluk K; Zuch A; Lukjan H; Tymińska-Brzósko R
Pol Tyg Lek; 1974 Nov; 29(46):1965-8. PubMed ID: 4279398
[No Abstract] [Full Text] [Related]
14. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
Chan JY; Movat HZ; Burrowes CE
Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
[No Abstract] [Full Text] [Related]
15. Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein.
Ogston D; Bennett B
Br Med Bull; 1978 May; 34(2):107-12. PubMed ID: 148934
[No Abstract] [Full Text] [Related]
16. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
Smith MA; Kerr MA
Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
Bork K; Kleist R; Hardt J; Witzke G
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
[TBL] [Abstract][Full Text] [Related]
18. Fluorogenic peptide substrates for proteases in blood coagulation, kallikrein-kinin and fibrinolysis systems.
Iwanaga S; Morita T; Kato H; Harada T; Adachi N; Sugo T; Maruyama I; Takada K; Kimura T; Sakakibara S
Adv Exp Med Biol; 1979; 120A():147-63. PubMed ID: 158955
[No Abstract] [Full Text] [Related]
19. Hydrolysis of plasma kallikrein by trypsin and plasmin and the formation of active fragments.
Sampaio CA; Vidmar S; Hamaguchi A; Sampaio MU
Adv Exp Med Biol; 1986; 198 Pt B():105-11. PubMed ID: 2949543
[TBL] [Abstract][Full Text] [Related]
20. Human inter-alpha-trypsin inhibitor. Limited proteolysis by trypsin, plasmin, kallikrein and granulocytic elastase and inhibitory properties of the cleavage products.
Dietl T; Dobrinski W; Hochstrasser K
Hoppe Seylers Z Physiol Chem; 1979 Sep; 360(9):1313-8. PubMed ID: 92450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
